Search results
A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination with Sofosbuvir for the Treatment of Post-Liver Transplant Subjects with Chronic Hepatitis C
… The primary objective of this program is to provide DCV for 24 weeks to be given in combination with SOF to subjects … of Daclatasvir (BMS-790052) in Combination with Sofosbuvir for the Treatment of Post-Liver Transplant Subjects with …
Last Modified:
A Randomized Trial Comparing the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
… the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for Treatment of Superficial Femoral and/or Proximal …
Last Modified:
A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection
… up study is observational and no treatment is provided for HCV. Trial Website: … A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to …
Last Modified:
Phase I Study of Talimogene Laherparepvec Administered Endoscopically for the Treatment of Locally Advanced or Metastatic Pancreas Cancer Refractory to at Least One Chemotherapy Regimen
… of Talimogene Laherparepvec Administered Endoscopically for the Treatment of Locally Advanced or Metastatic Pancreas …
Last Modified:
A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function.
… The study will consist of a primary study period through 26 weeks and a follow-up period through 52 weeks. Transplant … placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney …
Last Modified:
THRIVE: Thymira Indeterminate FNA Validation: A Validation study to establish the specificity and sensitivity of Thymira diagnostic test for patients with Indeterminate FNAs versus the standard pathological examination
… study of a new molecular diagnostic test, Thymira, for determining malignancy risk in indeterminate nodules. … the specificity and sensitivity of Thymira diagnostic test for patients with Indeterminate FNAs versus the standard …
Last Modified:
Use of Endoscopically Delivered Radiofrequency Ablation for the Treatment of Patients Who Have Undergone Roux-en-Y Gastric Bypass and Have Failed to Achieve/ Maintain Satisfactory Excess Body Weight Loss
… of radiofrequency ablation, delivered via endoscopy, for the treatment of weight regain or inadequate weight loss … not lose at least 40% of their excess weight are eligible for this study. … Use of Endoscopically Delivered Radiofrequency Ablation for the Treatment of Patients Who Have Undergone Roux-en-Y …
Last Modified:
Prospective Randomized Double Blind Placebo Controlled Trial of Rifaximin 550mg PO Twice Daily for Three Months to Prevent Recurrent Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C Virus Infection
… of a poorly-absorbable antibiotic (rifaximin) for the first three months after liver transplant will reduce … in this study. Subjects will be part of the study for approximately 1 year post transplant. Trial Website: … Placebo Controlled Trial of Rifaximin 550mg PO Twice Daily for Three Months to Prevent Recurrent Fibrosis in Liver …
Last Modified:
An Expanded Access Phase 2 Study of Sofosbuvir with Ribavirin and with or without Pegylated Interferon for 24 weeks in Subjects who have undergone Liver Transplantation and Who Have Aggressive, Recurrent Hepatitis C infection
… specific clinical sites at the request of an investigator for the treatment of individual subjects for whom there are no other treatment options. Subjects will be treated for 24 weeks with sofosbuvir (400mg QD) with RBV; pegylated … with Ribavirin and with or without Pegylated Interferon for 24 weeks in Subjects who have undergone Liver …
Last Modified:
A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects With Early Decompensated Liver Cirrhosis
… agent, is currently marketed as a 550 mg tablet for the reduction in risk of recurrent overt hepatic … of rifaximin SSD tablets or placebo tablets every day for 24 weeks. Trial Website: … Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects With Early …
Last Modified:
Our Heart Surgery Programs and Services
… is a world-leader in surgical and medical management for all types of heart disease and related conditions. Our … our unmatched surgical and medical expertise with the latest technologies to provide outstanding care for you and … grafts for coronary artery disease and heart attacks. Visit Coronary Care Valve Disease Care As part of the …
Last Modified:
Our Services
… to provide as many services as possible in a single visit, and all appointments and testing will be scheduled to … chiefs and chairs of Columbia University Medical Center for our experience caring for those with connective tissue … more or make an appointment with us, call 212-326-8949, or visit our primary location at 51 West 51st street, Suite 330. …
Last Modified:
Our Vascular Programs & Services
… call (646) 317-8282 or use our appointment request form . For the Eastern Vascular team in the Bronx, call (914) … to bring you the highest quality vein care available. Visit Vein Program Peripheral Artery Disease Care Peripheral … or lessened. To help with prevention, our team offers free vascular screenings at multiple locations throughout the …
Last Modified:
NewYork-Presbyterian The One: A State-of-the-Art Surgical Care Center in Westchester
… with a team of concierge coordinators to make sure your visit is smooth, easy, and efficient. Make an Appointment For all appointments, please call 914-327-2700 or complete … endoscopy rooms, and even recovery spaces. Access to the Latest Technology We've brought services and technologies …
Last Modified:
Reflux & Hiatal Hernia Program at Columbia
… help you feel better and get back to living fully. We care for patients from across New York City, New Jersey, … to recovery. Faster Recovery, Better Outcomes We offer the latest minimally invasive and robotic reflux and hiatal … endoscopy, endoFLIP and Bravo pH testing in a single visit. Beyond medical and surgical care, we provide …
Last Modified: